April 14, 2021 Bausch boosted ahead of eye spin-off NOV03 posts a pivotal win but the late-stage dry eye pipeline is crowded.
August 14, 2018 Amryt awaits crucial readout as it prepares rare disease push A looming interim analysis could make Amryt a player in epidermolysis bullosa – and boost its deal-making ambitions.
